For most people with androgenetic alopecia, GHK-Cu is best used as an add-on to existing therapies, not a replacement for them
Liposomal technology ensures phospholipid protection of glutathione from degradation in the digestive tract
In an RCT, the oral adjunct therapy Beta-hydroxybutyrate has exhibited favorable effects in improving the outcomes of COVID-19-related ARDS, notably by decreasing inflammation, oxidative stress, and levels of fatigue among patients (Shahtaghi et al., 2024)
However, the clinical benefit of glutamine supplementation may be limited to periods of remission, as another trial found that glutamine supplementation during a disease flare did not improve intestinal permeability (Ockenga 2005)
Petersen JA, Wilm BJ, von Meyenburg J, Schubert M, Seifert B, Najafi Y, et al